Email Print Share

News From the Field

'Wrapping' GleevecŪ Fights Drug-Resistant Cancer

May 1, 2007

This material is available primarily for archival purposes. Telephone numbers or other contact information may be out of date; please see current contact information at media contacts.

A study in this week's Cancer Research finds the anti-cancer drug Gleevec is far more effective against a drug-resistant strain of cancer when it wraps the target with a molecular bandage that seals out water from a critical area. The wrapping version of the drug--known as WBZ-7--was created, produced and tested by three research teams from Rice University and the University of Texas M. D. Anderson Cancer Center in Houston. Full Story

Rice University

The National Science Foundation (NSF) is an independent federal agency that supports fundamental research and education across all fields of science and engineering. In fiscal year (FY) 2018, its budget is $7.8 billion. NSF funds reach all 50 states through grants to nearly 2,000 colleges, universities and other institutions. Each year, NSF receives more than 50,000 competitive proposals for funding and makes about 12,000 new funding awards.

mail icon Get News Updates by Email 

Useful NSF Web Sites:
NSF Home Page:
NSF News:
For the News Media:
Science and Engineering Statistics:
Awards Searches: